Microtransplantation and Checkpoint Blockade Immunotherapy for Relapsed or Refractory B Cell Lymphomas

NCT03920631 · clinicaltrials.gov ↗

PHASE1

Phase

WITHDRAWN

Status

OTHER

Sponsor class

Stopped Lack of accrual

Conditions

B Cell Lymphomas

Interventions

DRUG: Nivolumab
BIOLOGICAL: Microtransplantation

Sponsor

Ahmed Galal, MD